Avadomide

N/A

Report date: 2023/12/14 17:55:39
NME

Base Information

Drug NameAvadomide
Drug Alias NameCC-122
ClassificationSmall molecules > Heterocyclic drugsSmall molecules > Molecular Glue
Mechanisms of ActionCereblon modulators
TargetsCereblon
Therapy Area/IndicationsCentral Nervous System LymphomaRenal InsufficiencyMultiple Myeloma +[10] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumCanadaUnited States +[10] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesCelgene Corp
China Registration ClassN/A

Develop Information

Active CompaniesBristol Myers Squibb SrlcompanyH Lee Moffitt Cancer Center & Research InstituteCelgene Corp
Inactive CompaniesN/A
Active IndicationsCentral Nervous System LymphomaMultiple MyelomaMelanoma +[7] 
Inactive IndicationsRenal InsufficiencyCarcinoma, HepatocellularLeukemia, Lymphocytic, Chronic, B-Cell

Other Information

ATC CodeN/A
Related LinksN/A